

Owens minor free#
Get a free copy of the research report on Owens & Minor (OMI).The Global Solutions segment offers a portfolio of products and services to healthcare providers and manufacturers. It operates through two segments, Global Solutions and Global Products. Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company in the United States and internationally. 95.69% of the stock is owned by institutional investors. AQR Capital Management LLC now owns 33,891 shares of the company’s stock valued at $1,066,000 after acquiring an additional 3,346 shares during the last quarter. Finally, AQR Capital Management LLC boosted its stake in Owens & Minor by 11.0% in the second quarter. now owns 7,538 shares of the company’s stock valued at $237,000 after acquiring an additional 1,375 shares during the last quarter. boosted its stake in Owens & Minor by 22.3% in the second quarter. MD now owns 33,774 shares of the company’s stock valued at $1,062,000 after acquiring an additional 767 shares during the last quarter. MD boosted its stake in Owens & Minor by 2.3% in the second quarter. Thrivent Financial for Lutherans now owns 74,774 shares of the company’s stock valued at $2,352,000 after acquiring an additional 13,347 shares during the last quarter. Thrivent Financial for Lutherans boosted its stake in Owens & Minor by 21.7% in the second quarter. bought a new stake in shares of Owens & Minor during the second quarter valued at approximately $986,000. Several large investors have recently added to or reduced their stakes in the company. 4.09% of the stock is owned by company insiders. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Following the completion of the transaction, the director now directly owns 27,000 shares of the company’s stock, valued at approximately $857,520. The stock was purchased at an average price of $31.76 per share, with a total value of $31,760.00. Henkel purchased 1,000 shares of the company’s stock in a transaction that occurred on Friday, July 15th. In other Owens & Minor news, Director Robert J. will post 3.04 earnings per share for the current year. On average, research analysts anticipate that Owens & Minor, Inc. During the same period in the prior year, the company posted $1.06 earnings per share. Owens & Minor’s revenue for the quarter was up. Owens & Minor had a net margin of 1.56% and a return on equity of 26.66%. The firm had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.53 billion. The company reported $0.76 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.76. Its manufacturing facilities are located in the United States, Thailand, and others.Owens & Minor ( NYSE:OMI – Get Rating) last issued its quarterly earnings data on Wednesday, August 3rd. Its home healthcare portfolio provides a range of chronic and acute care needs, including diabetes, ostomy, incontinence, wound care, home respiratory, obstructive sleep apnea and negative pressure wound therapy. Its Global Products segment manufactures and sources medical surgical products through its production and kitting operations. Its service offerings to healthcare providers include supplier management, analytics, inventory management, and clinical supply management. Its portfolio of medical and surgical supplies includes branded products purchased from manufacturers and its own products. The Global Solutions segment includes its United States distribution businesses (Medical Distribution and Patient Direct), outsourced logistics and value-added services business. It operates through two segments: Global Solutions and Global Products.

is a global healthcare solutions company.
